Omega-3 and -6 Fatty Acids, Plasma
1. Baseline and monitoring of individuals with known CVD (acute and chronic) to deterimine Rx and compliance. 2. Identify patients with known CVD risk with low omega-3 levels who may be candidates for supplementation/therapy. 3. Monitor patients on omega-3 supplementation/therapy to determine efficacy of treatment. 4. Potential role in risk reduction for non-CVD outcomes-aged related macular degeneration, RA, cancer, etc. (early data).
$202.00Price for members $101.50
Preparation: Overnight fasting is preferred. Please do not exercise prior to testing. It is best that your blood is taken in a rested state.